# Blinded Review: TIME_ANON_42
**Composite Score:** 7.8 / 10.0 (Rigor: 2.7/3.5 | Claims: 2.0/2.5 | Biology: 1.7/2.0 | Reproducibility: 1.4/2.0)
**Bias Category:** None (Methodologically Sound)
**Verdict:** Minor Revision
**Study Modality:** Wet-Lab Primary Experimental
**Technology Maturity:** Mature/Classical
**Epistemic Stage:** Basic/Mechanistic Discovery

---

### 1. Executive Summary

This manuscript investigates a non-canonical, RNA interference (RNAi)-independent function of *Drosophila melanogaster* Dicer-2 (Dcr-2) in innate immunity. Through a sequence of genetic, biochemical, and microbiological experiments in S2 cells and adult flies, the authors demonstrate that Dcr-2 positively regulates the Toll signaling pathway—as measured by *Drosomycin* (*Dros*) induction and survival following *Aspergillus fumigatus* challenge—without affecting the IMD pathway (*Diptericin*). Using *Ago2* and *r2d2* null mutants and dsRNA knockdowns as negative controls, the authors show that this function is independent of canonical siRNA pathway activity. Mechanistically, Dcr-2 does not alter *Toll* mRNA abundance or Toll protein stability, but directly binds the *Toll* mRNA 3' untranslated region (3'UTR) via its PAZ domain to promote posttranscriptional Toll protein expression.

The study is well-designed and employs orthogonal biochemical and genetic controls, including two non-overlapping dsRNAs against *dcr-2* and *ago2*, null mutant fly alleles (*Dcr-2^L811fsX*, *r2d2^1*, *Ago2^414*), epistatic rescue with ectopic Flag-Toll lacking the native 3'UTR, *in vitro* EMSA with purified recombinant full-length $\text{His}_8\text{-Dcr-2}$ and isolated domains, competitive squelching with exogenous *Toll* 3'UTR or isolated PAZ domain, and domain-deletion mutagenesis (`Dcr-2ΔPAZ`). The primary limitations are statistical (use of unadjusted two-tailed $t$-tests on $n = 3$ replicates without survival curve log-rank statistics or binding affinity titration curves) and a causal overreach in the viral infection section (Fig. 8), where the effect of *dcr-2* knockdown during FHV and VSV infection is attributed solely to the Toll 3'UTR mechanism despite Dcr-2's simultaneous canonical role in cleaving viral dsRNA.

---

### 2. Methodological & Statistical Audit

* **Survival Analysis Missing Censored Time-to-Event Testing (Fig. 2C):**
  In Fig. 2C, survival of adult flies challenged with *A. fumigatus* is plotted over 6 days ($n = 3$ independent cohorts of 20 flies [10 male, 10 female] per genotype, totaling 60 flies per group). However, the authors only plot mean $\pm$ SD daily survival percentages and do not report a formal Kaplan–Meier log-rank (Mantel–Cox) test or Cox proportional-hazards model accounting for within-vial clustering. Furthermore, the genetic background control for the *Dcr-2^L811fsX*, *r2d2^1*, and *Ago2^414* null alleles (Fig. 2D, E) relies on a general laboratory *yw* stock rather than isogenized or heterozygous littermate controls, although the consistency across both *Actin-Gal4 > UAS-dsRNA(Dcr-2)* versus *CyO* sibling controls (Fig. 2A–C) and two independent S2 dsRNAs (Fig. 1A–D) substantially mitigates background confounding.

* **Single-Concentration EMSA Without Dissociation Constant ($K_d$) Quantification:**
  In the gel mobility shift assays (Figs. 5B, 6B, 6D), purified recombinant proteins ($\text{His}_8\text{-Dcr-2}$, MBP-PAZ, MBP-RNase III, MBP-dsRBD, GST-helicase) were incubated at a single high protein concentration ($30\ \mu\text{M}$) against $0.1\ \mu\text{M}$ DIG-labeled *Toll* 3'UTR (a 300:1 molar excess). At $30\ \mu\text{M}$, weak or low-affinity RNA-binding domains can exhibit apparent shifting, and a dose-response titration series ($0.01\text{--}10\ \mu\text{M}$) is needed to estimate the apparent dissociation constant ($K_d$) and Hill coefficient. However, the specificity of the PAZ domain interaction is well-supported by negative domain controls (MBP-dsRBD and GST-helicase at $30\ \mu\text{M}$ show zero shift), negative RNA substrate controls (*Dif* and *dorsal* 3'UTRs in fig. S3), and *in vivo* RNA-IP competition in S2 cells (Figs. 4A–C, 7A–E).

* **Multiple Pairwise $t$-Tests Across Multi-Group qRT-PCR Panels:**
  In Figs. 1D, 1E, 2B, 2E, 3B, 3D, and 4B, qRT-PCR data normalized to *Rp49* ($n = 3$) are analyzed using two-tailed Student's $t$-tests without correction for multiple comparisons across genotypes/treatments. Because the observed effect sizes are large (3- to 8-fold reductions in *Dros* mRNA corroborated by Northern blots on the same samples), the qualitative conclusions are robust, but one-way ANOVA with Dunnett's or Tukey's post-hoc test should be used.

---

### 3. Biological / Experimental Grounding & Claim Proportionality

* **Claim that Dcr-2 is Required for Toll Signaling Independently of the Canonical siRNA Pathway: `[Well Supported]`**
  Both Northern blot and qRT-PCR assays in S2 cells (using two non-overlapping dsRNAs per gene) and in adult flies (using *Actin-Gal4* knockdown and *Dcr-2^L811fsX* null alleles) show that loss of Dcr-2, but not loss of core RISC components AGO2 or R2D2, suppresses basal and PGN/*M. luteus*-induced *Dros* expression without altering IMD-mediated *Dipt* induction (Figs. 1–2).

* **Claim that Dcr-2 Posttranscriptionally Regulates Toll Protein Expression via Direct PAZ-Domain Binding to the *Toll* 3'UTR: `[Well Supported]`**
  The authors systematically rule out transcriptional regulation of *Toll* mRNA (Fig. 3C, D) and protein degradation of Flag-Toll expressed from a construct lacking the endogenous 3'UTR (Fig. 3F). Chimeric `EGFP-Toll-3'UTR` reporter assays (Fig. 5C, D), competitive squelching by exogenous *Toll* 3'UTR (Fig. 4A, fig. S2B) or isolated Flag-PAZ (Fig. 7A, C), and loss of function in the `Dcr-2ΔPAZ` mutant (Fig. 7D, E) form a tight, internally consistent mechanistic chain.

* **Claim that Dcr-2 Catalytic Activity is Dispensable and that Dcr-2 Acts as a Viral Sensor for Toll Activation During FHV/VSV Infection: `[Moderately Supported]`**
  While the authors show that *Ago2* and *r2d2* are dispensable for Toll signaling and that `Dcr-2ΔPAZ` abolishes *Dros* induction, they did not test a catalytically dead RNase III point mutant of full-length Dcr-2 (nor ATPase-dead helicase mutant) to formally exclude a role for Dcr-2 enzymatic activity in 3'UTR remodeling. Moreover, in Fig. 8, knocking down *dcr-2* during FHV or VSV infection alters viral RNA replication via loss of antiviral RNAi, which confounds whether reduced *Dros* induction during viral infection is due to loss of viral dsRNA sensing or simply reduced baseline Toll receptor levels prior to infection.

---

### 4. Reproducibility & Data Completeness

* **Strengths:** Fly genotypes, stock sources, bacterial/fungal challenge protocols, vector backbones (`pMT/V5-His`, `pAc5.1/V5-His B`, `pFastBac1`, `pMAL-c2x`, `pGEX-6P-1`), restriction cloning sites, protein purification buffers, and antibody catalog numbers/dilutions are thoroughly documented in the Materials and Methods, with all PCR, dsRNA, and qRT-PCR primers provided in Table S1.
* **Minor Deficiencies:**
  1. Exact amino acid coordinate boundaries used to clone the isolated Dcr-2 domains (helicase, PAZ, RNase III, dsRBD) and the `Dcr-2ΔPAZ` internal deletion should be stated in the text alongside Table S1.
  2. Densitometric quantification across replicates should be provided for the Western and Northern blots (especially Fig. 3E, F and Fig. 5D) to complement the visual gel images.
